We are live on ! Find out more
UBS Group

UBS Group Portfolio holdings

AUM $666B
1-Year Est. Return 30.12%
 

UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.

This Fund
S&P 500
This Quarter Est. Return
+3.47%
1 Year Est. Return
+30.12%
3 Year Est. Return
+86.21%
5 Year Est. Return
+101.56%
10 Year Est. Return
+336.66%
AUM
$405B
AUM Growth
+$3.26B
Cap. Flow
-$4.73B
Cap. Flow %
-1.17%
Top 10 Hldgs %
17.59%
Holding
10,501
New
1,227
Increased
3,693
Reduced
4,131
Closed
1,043

Top Buys

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$1.12B
2
AAPL icon
Apple
AAPL
+$1.08B
3
MSFT icon
Microsoft
MSFT
+$1.05B
4
NKE icon
Nike
NKE
+$1.03B
5
GOOG icon
Alphabet (Google) Class C
GOOG
+$821M

Sector Composition

Rank Sector Weight
1 Technology 17.8%
2 Financials 8.25%
3 Healthcare 6.4%
4 Consumer Discretionary 5.85%
5 Communication Services 4.91%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CINT icon
8001
CI&T Inc
CINT
$445M
$5.19K ﹤0.01%
+998
New +$4.27K
CTHR
8002
DELISTED
Charles & Colvard Ltd
CTHR
$5.18K ﹤0.01%
3,031
+2,640
+675% +$7.11K
AMBO
8003
Ambow Education Holding
AMBO
$5.66M
$5.17K ﹤0.01%
4,307
-3,010
-41% -$4.46K
XELB icon
8004
Xcel Brands
XELB
$6.9M
$5.12K ﹤0.01%
867
+410
+90% +$2.94K
AFMD
8005
DELISTED
Affimed
AFMD
$5.1K ﹤0.01%
936
+908
+3,243% +$5.1K
SMXT icon
8006
Solarmax Technology
SMXT
$20.5M
$5.08K ﹤0.01%
+1,545
New +$13.8K
SJ icon
8007
Scienjoy Holding
SJ
$43.3M
$5.07K ﹤0.01%
5,340
+2,756
+107% +$2.68K
DUO
8008
Fangdd Network Group
DUO
$22.5M
$5.07K ﹤0.01%
+539
New +$5.01K
FTFT icon
8009
Future FinTech Group
FTFT
$1.76M
$5.05K ﹤0.01%
66
+59
+843% +$7.43K
LPL icon
8010
LG Display
LPL
$3.27B
$5.05K ﹤0.01%
1,226
-2,315
-65% -$8.95K
CRDL
8011
Cardiol Therapeutics
CRDL
$151M
$5.05K ﹤0.01%
2,500
-281
-10% -$596
MOTI icon
8012
VanEck Morningstar International Moat ETF
MOTI
$75.7M
$5.05K ﹤0.01%
161
-427
-73% -$13.6K
TOON icon
8013
Kartoon Studios
TOON
$36.6M
$5.04K ﹤0.01%
4,893
+1,962
+67% +$2.26K
QNTM
8014
Quantum Biopharma Class B Subordinate Voting Shares
QNTM
$18.9M
$5.03K ﹤0.01%
478
-89
-16% -$2.17K
ATGL
8015
Alpha Technology Group
ATGL
$132M
$5.02K ﹤0.01%
+1,813
New +$5.75K
EOSEW
8016
DELISTED
Eos Energy Enterprises Warrant
EOSEW
$5.02K ﹤0.01%
26,698
+26,594
+25,571% +$3.25K
INSG icon
8017
Inseego
INSG
$123M
$5.01K ﹤0.01%
470
-237
-34% -$1.38K
EVO icon
8018
Evotec
EVO
$689M
$4.94K ﹤0.01%
1,030
-736
-42% -$4.13K
FTRI icon
8019
First Trust Exchange-Traded Fund II First Trust Indxx Global Natural Resources Income ETF
FTRI
$125M
$4.94K ﹤0.01%
+381
New +$5.14K
ASLN
8020
DELISTED
ASLAN Pharmaceuticals Limited American Depositary Shares
ASLN
$4.93K ﹤0.01%
+2,056
New +$7.28K
KINS icon
8021
Kingstone Companies
KINS
$293M
$4.93K ﹤0.01%
+986
New +$4.5K
XTNT icon
8022
Xtant Medical Holdings
XTNT
$61.9M
$4.92K ﹤0.01%
7,809
-634
-8% -$506
AMZE
8023
Amaze Holdings
AMZE
$1.28M
$4.92K ﹤0.01%
44
+34
+340% +$3.66K
HITI
8024
High Tide
HITI
$196M
$4.91K ﹤0.01%
+2,221
New +$5.18K
PCSC
8025
DELISTED
Perceptive Capital Solutions
PCSC
$4.9K ﹤0.01%
+487
New +$4.91K

Similar funds

UBS Group's Q2 2024 Portfolio in Review

As of Q2 2024, UBS Group held 10,501 positions worth $405B, up 0.81% from $402B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

UBS Group's Q2 2024 filing shows 1,227 new, 3,693 increased, 4,131 reduced and 1,043 closed positions. Its largest new stake was SLB Ltd: 10,925,731 shares worth $515M. The largest sale was BioMarin Pharmaceuticals, an estimated $389M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 15% a quarter earlier, followed by Financials and Healthcare.

  • UBS Group's largest Q2 2024 buy was SLB Ltd: 10,925,731 shares worth $515M.
  • UBS Group added most to NVIDIA in Q2 2024, an estimated $1.12B increase.
  • UBS Group's biggest Q2 2024 reduction was BioMarin Pharmaceuticals, cutting an estimated $389M.
  • UBS Group fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $263M.
  • UBS Group's ten largest holdings make up 18% of its $405B portfolio in Q2 2024.
  • UBS Group opened 1,227 new positions and closed 1,043 in Q2 2024.
  • UBS Group's portfolio value rose 0.81% quarter-over-quarter to $405B.

Based on UBS Group's 13F filing for Q2 2024, filed 14 Aug 2024.